Diabetes is one of the two leading causes of kidney disease, and together with high blood pressure it accounts for more than 70% of all end-stage kidney failure. Roughly one in four people with type 1 diabetes and a similar proportion with type 2 diabetes develop chronic kidney disease (CKD). The damage happens slowly, often without symptoms for years, which is why screening matters so much.
How High Blood Sugar Damages the Kidneys
Your kidneys filter blood through millions of tiny structures called nephrons, each containing a cluster of blood vessels called a glomerulus. Chronically elevated blood sugar injures nearly every cell type in these structures, and the damage compounds over time.
High glucose causes the walls of the tiny blood vessels in the glomerulus to thicken and stiffen. It also triggers cells in the filtering unit to overproduce collagen and other structural proteins, which gradually clog the filter. At the same time, the specialized cells (podocytes) that form the kidney’s final sieve begin to change shape and die off, creating gaps that let protein leak into your urine. In the tubules that carry filtered fluid away, cells undergo similar changes that lead to scarring, or fibrosis, in the tissue surrounding the nephrons.
The net effect is a kidney that filters less efficiently and leaks more protein with each passing year. Because these changes happen at a microscopic level, you can lose a significant amount of kidney function before feeling anything at all.
Why High Blood Pressure Makes It Worse
Diabetes and high blood pressure interact synergistically in the kidneys. Diabetes impairs the kidney’s ability to regulate its own blood flow, so when systemic blood pressure rises, that extra mechanical force is transmitted directly into the delicate glomerular capillaries. Animal studies show that kidneys exposed to both high glucose and high blood pressure sustain dramatically more damage and leak far more protein than kidneys exposed to either condition alone.
Despite this, only about 36% of people with diabetes who take blood pressure medication actually reach the recommended target of below 130/80 mmHg. Tight control of both blood sugar and blood pressure appears necessary to meaningfully slow kidney disease progression.
How Quickly Kidney Disease Progresses
In a classic long-term study published in JAMA, the average time from diabetes diagnosis to the first sign of significant protein in the urine was about 17 years. Once protein appeared, early kidney function decline followed within roughly two years, and severe kidney failure arrived about four years after that. The rate of decline accelerated toward the end of the course.
These timelines vary widely depending on blood sugar control, blood pressure, genetics, and treatment. Modern medications have stretched these windows considerably for many people, but the general pattern still holds: a long silent phase, followed by a period of accelerating decline once damage becomes established.
Symptoms: What You Feel (and Don’t Feel)
The most important thing to understand is that most people with diabetic kidney disease have no symptoms at all during the early and middle stages. There is no pain, no obvious change in urination, nothing that signals the kidneys are struggling. The National Institute of Diabetes and Digestive and Kidney Diseases states plainly that the only way to know if you have diabetic kidney disease is to get your kidneys tested.
Symptoms appear late, when kidney function has already dropped severely. At that point you may notice swelling in your feet and ankles, fatigue, nausea, difficulty concentrating, and changes in how often you urinate. Kidney failure is defined as less than 15% of normal kidney function remaining, and by that stage, dialysis or transplant becomes necessary.
How Kidney Damage Is Detected
Two simple tests catch kidney disease early. The first is a urine test that measures your albumin-to-creatinine ratio (UACR), which detects protein leaking into urine. A result of 30 mg/g or higher signals possible kidney damage. Values between 30 and 300 mg/g indicate moderate protein leakage, while anything above 300 mg/g is considered severe and typically warrants a referral to a kidney specialist. Notably, standard urine dipstick tests used in some routine checkups can miss values in the 30 to 300 range entirely, so the specific UACR lab test is important.
The second test is a blood draw to estimate your glomerular filtration rate (eGFR), which reflects how well your kidneys are filtering. An eGFR below 60 for more than three months indicates chronic kidney disease, even if your urine protein is normal. Either an abnormal UACR or an abnormal eGFR alone is enough to raise the flag.
The American Diabetes Association recommends that people with type 2 diabetes get both tests at diagnosis and annually thereafter. For people with type 1 diabetes, annual screening should begin five years after diagnosis. If an initial UACR comes back elevated, it should be repeated at least twice over the following three to six months to confirm the result.
Medications That Protect the Kidneys
Several classes of medication have proven kidney-protective effects in people with diabetes. Blood pressure drugs that block the renin-angiotensin system (commonly known as ACE inhibitors and ARBs) have been a cornerstone of treatment for decades, reducing pressure inside the glomerulus and slowing protein leakage.
Newer drug classes have added significant protection. In a large comparative study, people with type 2 diabetes who started on SGLT2 inhibitors (a class of glucose-lowering medication that also works in the kidneys) had a 5-year CKD risk of 6.7%, compared with 8.2% for those on GLP-1 receptor agonists, another newer drug class. That translates to about a 19% lower relative risk of developing chronic kidney disease with SGLT2 inhibitors. They also reduced episodes of acute kidney injury by roughly 12% compared to GLP-1 drugs. GLP-1 receptor agonists, however, showed a slight edge in reducing protein leakage and mortality.
Current guidelines from the American Diabetes Association describe four “pillars” of kidney-protective therapy for people with type 2 diabetes and CKD: traditional blood pressure medications targeting the renin-angiotensin system, SGLT2 inhibitors, GLP-1 receptor agonists, and a newer class called nonsteroidal mineralocorticoid antagonists. Your doctor may use one or more of these depending on how advanced the kidney damage is.
Dietary Changes That Help
For people with diabetes whose kidney filtration rate has dropped below 60 (the threshold for CKD), guidelines recommend reducing daily protein intake to about 0.6 to 0.8 grams per kilogram of body weight. For a 175-pound person, that works out to roughly 48 to 64 grams of protein per day, which is less than many people eat. The goal is to reduce the workload on damaged nephrons, since processing protein is one of the kidney’s more demanding tasks.
For people with diabetes who don’t yet have significant kidney damage, keeping protein at the general population recommendation of about 0.8 grams per kilogram per day is considered reasonable. Calorie intake should stay in the range of 25 to 35 calories per kilogram daily to prevent muscle loss while following these lower-protein diets. A dietitian familiar with kidney disease can help you hit these targets without feeling deprived.
What You Can Control
The combination of tight blood sugar management, blood pressure control below 130/80, and the right medications can dramatically slow or even stall diabetic kidney disease. The silent nature of the condition makes annual screening the single most important step. Catching elevated protein in the urine at 30 mg/g rather than 300 mg/g gives you and your care team years of extra runway to intervene before irreversible damage sets in.